# Croda International PLC (CRDA.L): Analyzing a Specialty Chemicals Giant with a Lucrative 12.32% Upside Potential

- Link: https://www.directorstalkinterviews.com/croda-international-plc-crda-l-analyzing-a-specialty-chemicals-giant-with-a-lucrative-12-32-upside-potential/4121258804
- Published: 2026-08-03T03:02:59+01:00
- Author: Olivia Thompson

[Croda International PLC](https://www.directorstalkinterviews.com/ftse-company/croda-international/crdo.l)(
CRDA.L), a renowned player in the specialty chemicals sector, continues to capture
investor interest with its market positioning and promising growth outlook. Operating
within the basic materials sector, Croda is headquartered in Goole, United Kingdom,
and boasts a market capitalization of $4.47 billion. The company’s diverse portfolio
spans consumer care, life sciences, and industrial specialties, making it a versatile
choice for investors seeking exposure to the specialty chemicals industry.

**Current Market Performance**

As of the latest trading session, Croda International’s stock is priced at 3,205
GBp, marking a modest decline of 66.00 GBp or 0.02%. The stock’s 52-week range has
fluctuated between 2,439.00 GBp and 3,271.00 GBp, indicating a relatively stable
performance over the past year. With a 50-day moving average of 3,009.84 GBp and
a 200-day moving average of 2,871.66 GBp, the stock is trading above these key technical
indicators, suggesting a bullish trend in the short to medium term.

**Valuation and Financial Metrics**

Despite its robust market presence, Croda’s valuation metrics present a mixed picture.
The forward P/E ratio stands at an incredibly high 1,789.84, which may raise eyebrows
among value-focused investors. However, this is balanced by a positive revenue growth
of 2.90% and a return on equity of 3.68%, reflecting the company’s ability to generate
profits from its equity base.

The free cash flow of £80.2 million underscores Croda’s capability to sustain its
operations and continue rewarding shareholders, albeit the net income and several
valuation metrics are currently not available.

**Dividend and Payout Insights**

Croda International offers a dividend yield of 3.46%, which is attractive for income-
seeking investors. However, the payout ratio of 195.08% indicates that the company
is paying out more in dividends than it earns, which might not be sustainable in
the long run without an improvement in earnings.

**Analyst Ratings and Price Target**

Analysts remain optimistic about Croda’s future performance, with 10 buy ratings
and 4 hold ratings. The stock’s target price range is set between 3,190.00 GBp and
4,250.00 GBp, with an average target of 3,600.00 GBp. This suggests a potential 
upside of 12.32%, a compelling reason for investors to consider adding Croda to 
their portfolios.

**Technical Indicators and Momentum**

The technical momentum of Croda’s stock is supported by a MACD of 48.54 and an RSI(
14) of 46.44, suggesting that the stock is neither overbought nor oversold at current
levels. This technical setup could be indicative of a stable investment opportunity
with room for growth.

**Strategic Market Position**

Croda International’s strategic focus on consumer care products, biologics drug 
delivery, and industrial specialties like surfactants and phase change materials,
positions it well to benefit from diverse market demands across regions such as 
Europe, North America, and Asia. The company’s historical expertise, dating back
to its incorporation in 1925, further strengthens its credibility and potential 
for sustained success.

For individual investors, Croda International PLC offers a dynamic mix of income
and growth potential, albeit with some risks associated with its current payout 
levels and valuation metrics. Given the analyst consensus and technical indicators,
the stock presents a compelling opportunity for those willing to navigate the intricacies
of the specialty chemicals sector.

Share on:
